 |
 |
 |
|
Safety and Anti Anti-HCV Activity of Rescue Therapy with Intravenous Silibinin (LEGALON ) in Cirrhotic HIV/HCV-infected Subjects
|
|
|
Reported by Jules Levin
CROI 2012 March5-8 Seattle WA
Ana Moreno 1*, Carmen Quereda1, Rafael Barcena2, Santos del Campo 2, MariaJ. Perez-Elias1, JoseL. Casado1, MariaA. Galvez3, Rosario Pintor4, MariaL. Mateos5, and Santiago Moreno 1
Infectious Diseases1, Gastroenterology2, Clinical Pharmacology3, Pharmacy4 Microbiology (Hepatitis)5. Ramon Cajal. Diseases Gastroenterology Clinical Pharmacology Pharmacy and Microbiology (Viral Hepatitis) Hospital Ramn y Cajal Services of Infectious Madrid. Spain.





|
|
|
 |
 |
|
|